Lexeo Therapeutics Inc (LXEO) Implied Volatility Current

Tracking LXEO implied volatility helps you identify when options premiums on Lexeo Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Lexeo Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when LXEO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Lexeo Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For LXEO, tracking metrics like LXEO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on LXEO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease.

The company was incorporated in 2017 and is based in New York, New York.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where LXEO implied volatility sits today versus where it has been. Our scanner ranks Lexeo Therapeutics Inc implied volatility against its historical range, surfaces extremes in LXEO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Lexeo Therapeutics Inc IV is rich or cheap — measure it, then act on it.